
PainTEQ launched a first of its kind biomechanical study this month that explores the treatment of sacroiliac (SI) joint pain through a minimally invasive outpatient procedure using a posterior approach.
The study will explore the function and motion of test subjects’ bilateral joints that have been treated with LinQ™ Sacroiliac Joint Fusion, a less invasive alternative to traditional sacroiliac fusion.
The LinQ SI Joint Stabilization procedure is minimally invasive. The surgeon implants one small bone allograft into the SI joint through a small incision. Patients leave the hospital or surgery center the same day, and can usually resume daily living activities within two weeks.
As the SI joint gets more clinical consideration as a low back pain generator, medical device companies are increasingly focusing on this market segment. Segment leader SI-BONE is profiled in this BONEZONE® article, which names numerous other players in the segment.
PainTEQ launched a first of its kind biomechanical study this month that explores the treatment of sacroiliac (SI) joint pain through a minimally invasive outpatient procedure using a posterior approach.
The study will explore the function and motion of test subjects' bilateral joints that have been treated with LinQ™ Sacroiliac Joint...
PainTEQ launched a first of its kind biomechanical study this month that explores the treatment of sacroiliac (SI) joint pain through a minimally invasive outpatient procedure using a posterior approach.
The study will explore the function and motion of test subjects’ bilateral joints that have been treated with LinQ™ Sacroiliac Joint Fusion, a less invasive alternative to traditional sacroiliac fusion.
The LinQ SI Joint Stabilization procedure is minimally invasive. The surgeon implants one small bone allograft into the SI joint through a small incision. Patients leave the hospital or surgery center the same day, and can usually resume daily living activities within two weeks.
As the SI joint gets more clinical consideration as a low back pain generator, medical device companies are increasingly focusing on this market segment. Segment leader SI-BONE is profiled in this BONEZONE® article, which names numerous other players in the segment.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





